Armistice AUM: Charting New Frontiers in Health Care Investments
In the wake of the COVID-19 pandemic, the landscape of healthcare investments has significantly transformed. At the forefront of this evolution stands Armistice Capital, a hedge fund that has demonstrated a keen ability to navigate the complexities of the biotech and pharmaceutical sectors. With its assets under management (AUM) strategically deployed, Armistice has positioned itself as a key player in shaping the future of medical innovation....